[1] SAMOREZOV JE, ALSBERG E. Spatial regulation of controlled bioactive factor delivery for bone tissue engineering. Adv Drug Deliv Rev. 2015; 84:45-67.
[2] PARENT M, BARADARI H, CHAMPION E, et al. Design of calcium phosphate ceramics for drug delivery applications in bone diseases: A review of the parameters affecting the loading and release of the therapeutic substance. J Control Release. 2017;252:1-17.
[3] NAYAK AK, MAITY M, BARIK H, et al. Hydroxyapatite-based composites for orthopedic drug delivery and tissue engineering. Appl Adv Green Mater. 2021:293-320.doi.org/10.1016/B978-0-12-820484-9.00012-X
[4] NICHOL T, CALLAGHAN J, TOWNSEND R, et al. The antimicrobial activity and biocompatibility of a controlled gentamicin-releasing single-layer sol-gel coating on hydroxyapatite-coated titanium. Bone Joint J. 2021;103-B(3):522-529.
[5] RAINA DB, LIU Y, ISAKSSON H, et al. Synthetic hydroxyapatite: a recruiting platform for biologically active molecules. Acta Orthop. 2020; 91(2):126-132.
[6] KUMAR A, KARGOZAR S, BAINO F, et al. Additive Manufacturing Methods for Producing Hydroxyapatite and Hydroxyapatite-Based Composite Scaffolds: A Review. Front Mater. 2019;6:313.
[7] KARACAN I, COX N, DOWD A, et al. The synthesis of hydroxyapatite from artificially grown Red Sea hydrozoan coral for antimicrobacterial drug delivery system applications. J Aust Ceram Soc. 2021;57:399-407.
[8] PRAKASH J, KUMAR TS, VENKATAPRASANNA KS, et al. PVA/alginate/hydroxyapatite films for controlled release of amoxicillin for the treatment of periodontal defects. Appl Surf Sci. 2019;495:143543.
[9] IGNJATOVIĆ N, WU V, AJDUKOVIĆ Z, et al. Chitosan-PLGA polymer blends as coatings for hydroxyapatite nanoparticles and their effect on antimicrobial properties, osteoconductivity and regeneration of osseous tissues. Mater Sci Eng C Mater Biol Appl. 2016;60:357-364.
[10] STEVANOVIĆ M, DJOŠIĆ M, JANKOVIĆ A, et al. Antibacterial graphene-based hydroxyapatite/chitosan coating with gentamicin for potential applications in bone tissue engineering. J Biomed Mater Res A. 2020; 108(11):2175-2189.
[11] WANG S, SONG J, LI Y, et al. Grafting antibacterial polymer brushes from titanium surface via polydopamine chemistry and activators regenerated by electron transfer ATRP. React Funct Polym. 2019;140: 48-55.
[12] GHERASIM O, GRUMEZESCU AM, GRUMEZESCU V, et al. Bioactive Coatings Based on Hydroxyapatite, Kanamycin, and Growth Factor for Biofilm Modulation. Antibiotics (Basel). 2021;10(2):160.
[13] EPPERLEIN N, MENZEL F, SCHWIBBERT K, et al. Influence of femtosecond laser produced nanostructures on biofilm growth on steel. Appl Surf Sci. 2017;418:420-424.
[14] ZHANG Z, WANG T, ZHANG S, et al. A novel La3+ doped MIL spherical analogue used as antibacterial and anticorrosive additives for hydroxyapatite coating on titanium dioxide nanotube array. Appl Surf Sci. 2021;551:149425.
[15] SOBIA T, SABA Z, FAIZA Z, et al. Efficient drug delivery system for bone repair by tuning the surface of hydroxyapatite particles. RSC Adv. 2016; 6(107):104969-104978.
[16] PARENT M, MAGNAUDEIX A, DELEBASSÉE S, et al. Hydroxyapatite microporous bioceramics as vancomycin reservoir: Antibacterial efficiency and biocompatibility investigation. J Biomater Appl. 2016; 31(4):488-498.
[17] JADIDI A, DAVOODIAN F, SALAHINEJAD E. Effect of poly lactic-co-glycolic acid encapsulation on drug delivery kinetics from vancomycin-impregnated Ca-Mg silicate scaffolds. Prog Org Coatings. 2020;149:105970.
[18] LETT JA, SUNDARESWARI M, RAVICHANDRAN K, et al. Tailoring the morphological features of sol-gel synthesized mesoporous hydroxyapatite using fatty acids as an organic modifier. RSC Adv. 2019; 9(11):6228-6240.
[19] IONITA D, BAJENARU-GEORGESCU D, TOTEA G, et al. Activity of vancomycin release from bioinspired coatings of hydroxyapatite or TiO2 nanotubes. Int J Pharm. 2017;517(1-2):296-302.
[20] SHI X, WANG Y, REN L, et al. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair. Acta Biomater. 2009;5(5):1697-1707.
[21] DE TRIZIO A, SRISUK P, COSTA RR, et al. Natural based eumelanin nanoparticles functionalization and preliminary evaluation as carrier for gentamicin. React Funct Polym. 2017;114:38-48.
[22] AVIV M, BERDICEVSKY I, ZILBERMAN M. Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. J Biomed Mater Res A. 2007;83(1):10-19.
[23] MCNALLY MA, FERGUSON JY, LAU ACK, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: A prospective series of 100 cases. Bone Joint J. 2016;98-B(9):1289-1296.
[24] HUTTING KH, AAN DE STEGGE WB, VAN NETTEN JJ, et al. Surgical Treatment of Diabetic Foot Ulcers Complicated by Osteomyelitis with Gentamicin-Loaded Calcium Sulphate-Hydroxyapatite Biocomposite. J Clin Med. 2021;10(2):371.
[25] ZHANG J, WANG Q, WANG A. In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices. Acta Biomater. 2010;6(2):445-454.
[26] FORTINEAU J, TRAN-HUU-HUE LP, GALASSI C, et al. Characterisation and electroacoustic modelling of porous piezoceramics with graded porosity for ultrasonic transducer applications. Adv Appl Ceram. 2010; 109(3):184-188.
[27] CHEN L, MCCRATE JM, LEE JCM, et al. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology. 2011;22(10):105708.
[28] MONDAL S, DOROZHKIN SV, PAL U. Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018;10(4):e1504.
[29] KHALF A, MADIHALLY SV. Recent advances in multiaxial electrospinning for drug delivery. Eur J Pharm Biopharm. 2017;112:1-17.
[30] IGWE JC, MIKAEL PE, NUKAVARAPU SP. Design, fabrication and in vitro evaluation of a novel polymer-hydrogel hybrid scaffold for bone tissue engineering. J Tissue Eng Regen Med. 2014;8(2):131-142.
[31] MA M, YUAN ZF, CHEN XJ, et al. A facile preparation of novel multifunctional vectors by non-covalent bonds for co-delivery of doxorubicin and gene. Acta Biomater. 2012;8(2):599-607.
[32] ZHENG F, WANG S, WEN S, et al. Characterization and antibacterial activity of amoxicillin-loaded electrospun nano-hydroxyapatite/poly(lactic-co-glycolic acid) composite nanofibers. Biomaterials. 2013; 34(4):1402-1412.
[33] LIU F, WANG X, CHEN T, et al. Hydroxyapatite/silver electrospun fibers for anti-infection and osteoinduction. J Adv Res. 2019;21:91-102.
[34] ALVAREZ H, CASTRO C, MOUJIR L, et al. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis. J Biomed Mater Res B Appl Biomater. 2008;85(1):93-104.
[35] DOU XC, ZHU XP, ZHOU J, et al. Minocycline-released hydroxyapatite-gelatin nanocomposite and its cytocompatibility in vitro. Biomed Mater. 2011;6(2):025002.
[36] BARROUG A, KUHN L T, GERSTENFELD LC, et al. Interactions of cisplatin with calcium phosphate nanoparticles: In vitro controlled adsorption and release. J Orthop Res. 2004;22(4):703-708.
[37] PANDITA D, KUMAR S, LATHER V. Hybrid poly(lactic-co-glycolic acid) nanoparticles: Design and delivery prospectives. Drug Discov Today. 2015;20(1):95-104.
[38] GHITMAN J, BIRU EI, STAN R, et al. Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine. Mater Des. 2020;193:108805.
[39] JOSHY MIA, ELAYARAJA K, SAKTHIVEL N, et al. Freeze dried cross linking free biodegradable composites with microstructures for tissue engineering and drug delivery application. Mater Sci Eng C Mater Biol Appl. 2013;33(1):466-474.
[40] BOSE S, SARKAR N, BANERJEE D. Effects of PCL, PEG and PLGA polymers on curcumin release from calcium phosphate matrix for in vitro and in vivo bone regeneration. Mater Today Chem. 2018;8:110-120.
[41] DORATI R, DETRIZIO A, MODENA T, et al. Biodegradable scaffolds for bone regeneration combined with drug-delivery systems in osteomyelitis therapy. Pharmaceuticals (Basel). 2017;10(4):96.
[42] MACHA IJ, BEN-NISSAN B, SANTOS J, et al. Hydroxyapatite/PLA biocomposite thin films for slow drug delivery of antibiotics for the treatment of bone and implant-related infections. Key Eng Mater. 2016;696:271-276.
[43] LIU H, ZHANG L, SHI P, et al. Hydroxyapatite/polyurethane scaffold incorporated with drug-loaded ethyl cellulose microspheres for bone regeneration. J Biomed Mater Res B Appl Biomater. 2010;95(1):36-46.
[44] AKKINENI AR, LUO Y, SCHUMACHER M, et al. 3D plotting of growth factor loaded calcium phosphate cement scaffolds. Acta Biomater. 2015;27:264-274.
[45] FERRAZ MP, MATEUS AY, SOUSA JC, et al. Nanohydroxyapatite microspheres as delivery system for antibiotics: Release kinetics, antimicrobial activity, and interaction with osteoblasts. J Biomed Mater Res A. 2007;81(4):994-1004.
[46] SON JS, APPLEFORD M, ONG JL, et al. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres. J Control Release. 2011;153(2):133-140.
[47] THOMPSON S, TOWNSEND R. Pharmacological agents for soft tissue and bone infected with MRSA: Which agent and for how long? Injury. 2011;42 Suppl 5:S7-10.
[48] LI Z, YUBAO L, AIPING Y, et al. Preparation and in vitro investigation of chitosan/nano-hydroxyapatite composite used as bone substitute materials. J Mater Sci Mater Med. 2005;16(3):213-219.
[49] LETT JA, SAGADEVAN S, PRABHAKAR JJ, et al. Drug Leaching Properties of Vancomycin Loaded Mesoporous Hydroxyapatite as Bone Substitutes. Processes. 2019;7(11):826.
[50] POUNTOS I, GEORGOULI T, BIRD H, et al. The effect of antibiotics on bone healing: Current evidence. Expert Opin Drug Saf. 2011;10(6):935-945.
[51] KREMERS HM, NWOJO ME, RANSOM JE, et al. Trends in the epidemiology of osteomyelitis a population-based study, 1969 to 2009. J Bone Joint Surg Am. 2015;97(10):837-845.
[52] KRISHNAN AG, JAYARAM L, BISWAS R, et al. Evaluation of Antibacterial Activity and Cytocompatibility of Ciprofloxacin Loaded Gelatin–Hydroxyapatite Scaffolds as a Local Drug Delivery System for Osteomyelitis Treatment. Tissue Eng Part A. 2015;21(7-8):1422-1431.
[53] PRESHAW PM, HEFTI AF, JEPSEN S, et al. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis: A review. J Clin Periodontol. 2004;31(9):697-707.
[54] WANG Q, CHEN C, LIU W, et al. Levofloxacin loaded mesoporous silica microspheres/nanohydroxyapatite/ polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects. Sci Rep. 2017;7:41808.
[55] VARONI E, LODI G, CARRASSI A. Chlorhexidine (CHX) in dentistry: State of the art Tissue regeneration View project Phytotherapy Research View project. Minerva Stomatol. 2012;61:399-419.
[56] DE SOUZA CAS, COLOMBO APV, SOUTO RM, et al. Adsorption of chlorhexidine on synthetic hydroxyapatite and in vitro biological activity. Colloids Surf B Biointerfaces. 2011;87(2):310-318.
[57] SORIANO-SOUZA CA, ROSSI AL, MAVROPOULOS E, et al. Chlorhexidine-loaded hydroxyapatite microspheres as an antimicrobial delivery system and its effect on in vivo osteo-conductive properties. J Mater Sci Mater Med. 2015;26(4):166.
[58] BAHAR AA, REN D. Antimicrobial peptides. Pharmaceuticals (Basel). 2013;6(12):1543-1575.
[59] KOSIKOWSKA P, LESNER A. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015). Expert Opin Ther Pat. 2016; 26(6):689-702.
[60] YAZICI H, HABIB G, BOONE K, et al. Self-assembling antimicrobial peptides on nanotubular titanium surfaces coated with calcium phosphate for local therapy. Mater Sci Eng C Mater Biol Appl. 2019; 94:333-343.
[61] BACALUM M, RADU M. Cationic antimicrobial peptides cytotoxicity on mammalian cells: An analysis using therapeutic index integrative concept. Int J Pept Res Ther. 2015;21(1):47-55.
[62] MUELLER B, TRECCANI L, REZWAN K. Antibacterial active open-porous hydroxyapatite/lysozyme scaffolds suitable as bone graft and depot for localised drug delivery. J Biomater Appl. 2017;31(8):1123-1134.
[63] DENRY I, KUHN L T. Design and characterization of calcium phosphate ceramic scaffolds for bone tissue engineering. Dent Mater. 2016;32(1): 43-53.
[64] ALKHRAISAT MH, RUEDA C, CABREJOS-AZAMA J, et al. Loading and release of doxycycline hyclate from strontium-substituted calcium phosphate cement. Acta Biomater. 2010;6(4):1522-1528.
[65] OTSUKA M, NAKAHIGASHI Y, MATSUDA Y, et al. A novel skeletal drug delivery system using self‐setting calcium phosphate cement. 7. Effect of biological factors on indomethacin release from the cement loaded on bovine bone. J Pharm Sci. 1994;83(11):1569-1573.
[66] PROKOPOWICZ M, SZEWCZYK A, SKWIRA A, et al. Biphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery system. Drug Deliv Transl Res. 2020;10(2):455-470.
|